Alivus Life Sciences Limited (ALIVUS) Share Analysis
NSE · Healthcare · Healthcare
Alivus Life Sciences Limited (NSE: ALIVUS) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 21 Sep 2026, the share price was ₹1,431.00, market capitalisation ₹17,566 Cr, P/E 50.
Get the AI verdict on ALIVUS: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
ALIVUS price and valuation
- Share price
- ₹1,431.00
- Market cap
- ₹17,566 Cr
- P/E ratio
- 50
- P/B ratio
- 5.28
- EPS
- ₹49.08
- Book value per share
- ₹271.02
- Dividend yield
- 0.35%
ALIVUS profitability and growth
- ROE
- -
- ROCE
- -
- Debt to equity
- 0.02
- Revenue growth (3 yr)
- -
- Revenue growth (5 yr)
- -
- Profit growth (3 yr)
- -
- Profit growth (5 yr)
- -
ALIVUS 52-week range
- 52-week high
- ₹1,493.80
- 52-week low
- ₹819.00
- Face value
- ₹2.00
ALIVUS shareholding pattern
- Promoters
- 74.87%
- FIIs
- 5.54%
- DIIs
- 7.18%
- Public
- 12.42%
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.